Literature DB >> 23161603

Protein and peptide profiling as a tool for biomarker discovery in depression.

Khaled Alawam1, Ed Dudley, Rossen Donev, Johannes Thome.   

Abstract

This study sought to determine whether protein and/or peptide profiles from serum were able to distinguish patients suffering from depression from healthy control subjects and thereby act as biomarker candidates with potential diagnostic value. Serum samples were collected from patients (n = 39) and controls (n = 30). A C8 magnetic bead protocol was used to prepare serum proteins, while a microextraction C18 packed tip was used to isolate serum peptides. Both protein and peptide profiles were recorded by MALDI-MS and the data were exported for further analysis. No protein signals differentiated patients from controls and principle component analysis of the entire peptide profile did not allow for distinct clustering of the two groups. Further analysis of individual peptides however identified three peptide signals whose intensities were significantly different between patients and control subjects. The efficacy of these potential biomarker candidates to identify the patients was therefore studied using a receiver operating characteristic (ROC) curve and the combined use of all three candidates together offered the most specific and sensitive identification of true positive cases of depression.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23161603     DOI: 10.1002/elps.201200248

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  4 in total

1.  Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia.

Authors:  Khaled Al Awam; Ida Sibylle Haußleiter; Ed Dudley; Rossen Donev; Martin Brüne; Georg Juckel; Johannes Thome
Journal:  J Neural Transm (Vienna)       Date:  2014-05-01       Impact factor: 3.575

Review 2.  The promise of biomarkers in diagnosing major depression in primary care: the present and future.

Authors:  Eva E Redei; Neha S Mehta
Journal:  Curr Psychiatry Rep       Date:  2015-08       Impact factor: 5.285

Review 3.  Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future.

Authors:  Ashley L Comes; Sergi Papiol; Thorsten Mueller; Philipp E Geyer; Matthias Mann; Thomas G Schulze
Journal:  Transl Psychiatry       Date:  2018-08-16       Impact factor: 6.222

4.  Profiling of schizophrenia-associated serum peptides by MALDI-TOF-MS.

Authors:  Yingli Fu; Na Zhou; Yaqin Yu; Huiping Zhang; Yaoyao Sun; Mingyuan Zhang; Xin Chen; Yueying Wang; Qiong Yu
Journal:  J Neural Transm (Vienna)       Date:  2019-11-30       Impact factor: 3.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.